ARCHIVES

NIH Clinical Trials Committee Adopts Recommendations For Safety Monitoring

This article is from The Cancer Letter archive.

Vol. 05 No. 25 | June 22, 1979

Download PDF Visit The Full Archive

Related Articles

Diptheria Toxin Prompts Immune System To Kill Cancer

December 29, 2006

Navelbine+Herceptin: 78% Response In Breast Cancer

November 29, 2002

Recombinant Protein C Cuts Risk Of Sepsis Death

February 22, 2002

ODAC Recommends Approval of Evista for Breast Cancer Risk Reduction.

July 27, 2007

Trastuzumab Showed Improved Survival In Stage IV Breast Cancer with CNS Metastases

August 26, 2011

IOM Committee Will Probe Duke Scandal Together With Other “Omics” Case Studies

January 7, 2011